Literature DB >> 22427021

Transient compensatory smoking in response to placebo cigarettes.

David A Macqueen1, Bryan W Heckman, Melissa D Blank, Kate Janse Van Rensburg, David E Evans, David J Drobes.   

Abstract

RATIONALE: To address the public health problems caused by smoking, researchers have suggested a gradual reduction in the nicotine content of cigarettes. There remain concerns, however, about the potential for smokers to compensate for reductions in nicotine content by altering their smoking behavior. Such compensatory behaviors may negate any potential cessation and/or harm reduction benefits.
OBJECTIVE: The purpose of this study was to quantify smoking behavior (e.g., puff number, volume, duration, interpuff interval, and peak flow) in response to cigarettes, varying only in nicotine content, administered repeatedly.
METHODS: Sixty-seven dependent smokers participated in this two-session, within-subject study. Moderate nicotine content and placebo cigarettes (Quest© brand) were administered in a double-blind and counterbalanced manner. Each session required 12 h of tobacco abstinence and included four ad lib smoking bouts of the condition-assigned cigarette with 40 minutes separating each bout.
RESULTS: Placebo cigarettes produced increases in total puff volume and duration and decreases in total interpuff interval relative to cigarettes with moderate nicotine content. Differences in total puff volume and duration generally dissipated across smoking bouts, with differences in total puff volume nonexistent by the third and fourth bouts.
CONCLUSIONS: Placebo cigarettes produce compensatory smoking during initial exposures; however, these effects appear to be short lived. These findings are consistent with the previous work where smoking compensation has been observed in response to a single cigarette, but not over several days of smoking.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22427021      PMCID: PMC3802524          DOI: 10.1007/s00213-012-2685-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  38 in total

1.  Long-term effects of switching to cigarettes with lower tar and nicotine yields.

Authors:  A R Guyatt; A J Kirkham; D C Mariner; A G Baldry; G Cumming
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Withdrawal-suppressing effects of a novel smoking system: comparison with own brand, not own brand, and de-nicotinized cigarettes.

Authors:  A R Buchhalter; L Schrinel; T Eissenberg
Journal:  Nicotine Tob Res       Date:  2001-05       Impact factor: 4.244

3.  Establishing a nicotine threshold for addiction. The implications for tobacco regulation.

Authors:  N L Benowitz; J E Henningfield
Journal:  N Engl J Med       Date:  1994-07-14       Impact factor: 91.245

4.  Puff volume increases when low-nicotine cigarettes are smoked.

Authors:  R I Herning; R T Jones; J Bachman; A H Mines
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-18

5.  Relationship between cigarette yields, puffing patterns, and smoke intake: evidence for tar compensation?

Authors:  S R Sutton; M A Russell; R Iyer; C Feyerabend; Y Saloojee
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

6.  Nicotine maintains robust self-administration in rats on a limited-access schedule.

Authors:  W A Corrigall; K M Coen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 7.  Nicotine self-administration.

Authors:  K A Perkins
Journal:  Nicotine Tob Res       Date:  1999       Impact factor: 4.244

8.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

9.  A comparison of nicotine and cocaine self-administration in the dog: fixed-ratio and progressive-ratio schedules of intravenous drug infusion.

Authors:  M E Risner; S R Goldberg
Journal:  J Pharmacol Exp Ther       Date:  1983-02       Impact factor: 4.030

10.  Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum.

Authors:  N L Benowitz; H Porchet; L Sheiner; P Jacob
Journal:  Clin Pharmacol Ther       Date:  1988-07       Impact factor: 6.875

View more
  21 in total

1.  Randomized Trial of Reduced-Nicotine Standards for Cigarettes.

Authors:  Eric C Donny; Rachel L Denlinger; Jennifer W Tidey; Joseph S Koopmeiners; Neal L Benowitz; Ryan G Vandrey; Mustafa al'Absi; Steven G Carmella; Paul M Cinciripini; Sarah S Dermody; David J Drobes; Stephen S Hecht; Joni Jensen; Tonya Lane; Chap T Le; F Joseph McClernon; Ivan D Montoya; Sharon E Murphy; Jason D Robinson; Maxine L Stitzer; Andrew A Strasser; Hilary Tindle; Dorothy K Hatsukami
Journal:  N Engl J Med       Date:  2015-10       Impact factor: 91.245

2.  The Public Health Gains Had Cigarette Companies Chosen to Sell Very Low Nicotine Cigarettes.

Authors:  David T Levy; K Michael Cummings; Bryan W Heckman; Yameng Li; Zhe Yuan; Tracy T Smith; Rafael Meza
Journal:  Nicotine Tob Res       Date:  2021-02-16       Impact factor: 4.244

3.  Comparison of puff topography, toxicant exposure, and subjective effects in low- and high-frequency waterpipe users: a double-blind, placebo-control study.

Authors:  Caroline O Cobb; Melissa D Blank; Alejandra Morlett; Alan Shihadeh; Ezzat Jaroudi; Nareg Karaoghlanian; Barbara Kilgalen; Janet Austin; Michael F Weaver; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2014-09-25       Impact factor: 4.244

4.  The Impact of Exclusive Use of Very Low Nicotine Cigarettes on Compensatory Smoking: An Inpatient Crossover Clinical Trial.

Authors:  Eric C Donny; Matthew J Carpenter; Tracy T Smith; Joseph S Koopmeiners; Cassidy M White; Rachel L Denlinger-Apte; Lauren R Pacek; Víctor R De Jesús; Lanqing Wang; Clifford Watson; Benjamin C Blount; Dorothy K Hatsukami; Neal L Benowitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02-26       Impact factor: 4.254

5.  Mouth-Level Nicotine Intake Estimates from Discarded Filter Butts to Examine Compensatory Smoking in Low Nicotine Cigarettes.

Authors:  Tracy T Smith; Joseph S Koopmeiners; Dorothy K Hatsukami; Katelyn M Tessier; Neal L Benowitz; Sharon E Murphy; Andrew A Strasser; Jennifer W Tidey; Benjamin C Blount; Liza Valentin; Roberto Bravo Cardenas; Clifford Watson; James L Pirkle; Eric C Donny
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02-26       Impact factor: 4.254

6.  Strategies to Reduce Illicit Trade of Regular Nicotine Tobacco Products After Introduction of a Low-Nicotine Tobacco Product Standard.

Authors:  Kurt M Ribisl; Dorothy K Hatsukami; Jidong Huang; Rebecca S Williams; Eric C Donny
Journal:  Am J Public Health       Date:  2019-07       Impact factor: 9.308

7.  Behavioral Economic Purchase Tasks to Estimate Demand for Novel Nicotine/tobacco Products and Prospectively Predict Future Use: Evidence From The Netherlands.

Authors:  Bryan W Heckman; K Michael Cummings; Georges J Nahas; Marc C Willemsen; Richard J O'Connor; Ron Borland; Alexander A Hirsch; Warren K Bickel; Matthew J Carpenter
Journal:  Nicotine Tob Res       Date:  2019-05-21       Impact factor: 4.244

8.  A Randomized Controlled Trial of Progressively Reduced Nicotine Content Cigarettes on Smoking Behaviors, Biomarkers of Exposure, and Subjective Ratings.

Authors:  Melissa Mercincavage; Valentina Souprountchouk; Kathy Z Tang; Rachel L Dumont; E Paul Wileyto; Steven G Carmella; Stephen S Hecht; Andrew A Strasser
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-04-27       Impact factor: 4.254

Review 9.  Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation.

Authors:  Eric C Donny; Dorothy K Hatsukami; Neal L Benowitz; Alan F Sved; Jennifer W Tidey; Rachel N Cassidy
Journal:  Prev Med       Date:  2014-06-23       Impact factor: 4.018

10.  Smoking Topography Characteristics of Very Low Nicotine Content Cigarettes, With and Without Nicotine Replacement, in Smokers With Schizophrenia and Controls.

Authors:  Jennifer W Tidey; Rachel N Cassidy; Mollie E Miller
Journal:  Nicotine Tob Res       Date:  2016-03-19       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.